These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716 [TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells. Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855 [TBL] [Abstract][Full Text] [Related]
18. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Soeda J; Morgan M; McKee C; Mouralidarane A; Lin C; Roskams T; Oben JA Biochem Biophys Res Commun; 2012 Jan; 417(1):17-22. PubMed ID: 22108052 [TBL] [Abstract][Full Text] [Related]
19. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro. Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327 [TBL] [Abstract][Full Text] [Related]
20. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]